References
- Blázquez-Fernández, C., N. González-Prieto, and P. Moreno-Mencía. 2013. “Pharmaceutical Expenditure as a Determinant of Health Outcomes in EU Countries.” Estudios De Economía Aplicada 31 (2): 379–396.
- Cleeren, K., L. Lamey, J. H. Meyer, and K. De Ruyter. 2015. “How Business Cycles Affect the Healthcare Sector: A Cross‐country Investigation.” Health Economics. Advance online publication. doi:10.1002/hec.3187.
- Hansen, C. 2012. “The Relation between Wealth and Health: Evidence from a World Panel of Countries.” Economics Letters 115 (2): 175–176. doi:10.1016/j.econlet.2011.12.031.
- Hodrick, R. J., and E. C. Prescott. 1997. “Postwar U.S. Business Cycles: An Empirical Investigation.” Journal of Money, Credit, and Banking 29 (1): 1–16. doi:10.2307/2953682.
- Kumar, S. 2013. “Systems GMM Estimates of the Health Care Spending and GDP Relationship: A Note.” The European Journal of Health Economics 14 (3): 503–506. doi:10.1007/s10198-012-0394-7.
- Lamey, L., B. Deleersnyder, J. B. E. Steenkamp, and M. G. Dekimpe. 2012. “The Effect of Business-Cycle Fluctuations on Private-Label Share: What Has Marketing Conduct Got to Do with It?” Journal of Marketing 76 (1): 1–19. doi:10.1509/jm.09.0320.
- Moreno-Torres, I., J. Puig-Junoy, and J. M. Raya. 2011. “The Impact of Repeated Cost Containment Policies on Pharmaceutical Expenditure: Experience in Spain.” The European Journal of Health Economics 12 (6): 563–573. doi:10.1007/s10198-010-0271-1.
- OECD Health Statistics. 2014. http://www.oecd.org/els/health-systems/health-data.htm
- Shi, L., H. Y. Yang, G. Cheng, and Q. Meng. 2014. “Time Trends and Determinants of Pharmaceutical Expenditure in China (1990–2009).” PharmacoEconomics 32 (3): 257–264. doi:10.1007/s40273-013-0072-3.